Ashleigh Murphy-Beiner
Clinical Researcher
Papers
Trials
Key Impact
Recognised for empirical and qualitative work on the aftereffects of psychedelic experiences, emphasising extended difficulties, coping and integration as well as psychological outcomes after ceremonial and clinical use.
Background & Research
A. Murphy-Beiner is a clinical researcher active in contemporary psychedelic science whose published and in-preparation work centres on the psychological sequelae of psychedelic use and on strategies for coping and integration. Their research portfolio, drawn from mixed-methods, qualitative and survey-based studies, includes investigation of ayahuasca’s ‘afterglow’ and its associations with mindfulness and cognitive flexibility; a mixed-methods study and qualitative analyses documenting extended difficulties following psychedelic use; and interview work exploring ontological shock and existential distress after powerful psychedelic experiences.
Murphy-Beiner has also contributed to research comparing therapeutic outcomes of psilocybin-assisted therapy against conventional antidepressant treatment (psilocybin therapy v. escitalopram), with interest in personality change and broader mental-health outcomes. Across these projects they emphasise rigorous qualitative methodology, participant-centred descriptions of challenging experiences, and practical supports and coping strategies for people experiencing protracted difficulties after psychedelic sessions. (Note: the full given name was not available in the supplied sources.)